Roles of Werner syndrome protein in protection of genome integrity

DNA Repair

Volumn 9, Issue 3, 2010, Pages 331-344

  Rossi, Marie L ^a   Ghosh, Avik K ^a   Bohr, Vilhelm A ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

RecQ helicases; Werner Syndrome; WRN

Indexed keywords

DOUBLE STRANDED DNA; WERNER SYNDROME PROTEIN;

CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; DNA MODIFICATION; DNA RECOMBINATION; DNA REPAIR; DNA REPLICATION; DNA TRANSCRIPTION; EPIGENETICS; EXCISION REPAIR; GENE CONTROL; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA TRANSLATION; TELOMERE; WERNER SYNDROME;

ANIMALS; DNA; DNA REPAIR; DNA REPLICATION; GENOME; HUMANS; RECQ HELICASES; WERNER SYNDROME;

CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE; XENOPUS LAEVIS;

EID: 76749168005     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2009.12.011     Document Type: Review

References (244)

1. Bohr V.A. Rising from the RecQ-age: the role of human RecQ helicases in genome maintenance. Trends Biochem. Sci. 33 (2008) 609-620
2. Brosh Jr. R.M., and Bohr V.A. Human premature aging, DNA repair and RecQ helicases. Nucleic Acids Res. 35 (2007) 7527-7544
3. Chu W.K., and Hickson I.D. RecQ helicases: multifunctional genome caretakers. Nat. Rev. Cancer (2009)
4. Hanada K., and Hickson I.D. Molecular genetics of RecQ helicase disorders. Cell Mol. Life Sci. 64 (2007) 2306-2322
5. Singh D.K., Ahn B., and Bohr V.A. Roles of RECQ helicases in recombination based DNA repair, genomic stability and aging. Biogerontology 10 (2009) 235-252
6. Bachrati C.Z., and Hickson I.D. RecQ helicases: guardian angels of the DNA replication fork. Chromosoma 117 (2008) 219-233
7. Kusumoto R., Muftuoglu M., and Bohr V.A. The role of WRN in DNA repair is affected by post-translational modifications. Mech. Ageing Dev. 128 (2007) 50-57
8. Ding S.L., and Shen C.Y. Model of human aging: recent findings on Werner's and Hutchinson-Gilford progeria syndromes. Clin. Interv. Aging 3 (2008) 431-444
9. Muftuoglu M., Oshima J., von K.C., Cheng W.H., Leistritz D.F., and Bohr V.A. The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis. Hum. Genet. 124 (2008) 369-377
10. Multani A.S., and Chang S. WRN at telomeres: implications for aging and cancer. J. Cell Sci. 120 (2007) 713-721
11. Opresko P.L. Telomere ResQue and preservation-roles for the Werner syndrome protein and other RecQ helicases. Mech. Ageing Dev. 129 (2008) 79-90
12. Sidorova J.M. Roles of the Werner syndrome RecQ helicase in DNA replication. DNA Repair (Amst) 7 (2008) 1776-1786
13. Huang S., Lee L., Hanson N.B., Lenaerts C., Hoehn H., Poot M., Rubin C.D., Chen D.F., Yang C.C., Juch H., Dorn T., Spiegel R., Oral E.A., Abid M., Battisti C., Lucci-Cordisco E., Neri G., Steed E.H., Kidd A., Isley W., Showalter D., Vittone J.L., Konstantinow A., Ring J., Meyer P., Wenger S.L., von H.A., Wollina U., Schuelke M., Huizenga C.R., Leistritz D.F., Martin G.M., Mian I.S., and Oshima J. The spectrum of WRN mutations in Werner syndrome patients. Hum. Mutat. 27 (2006) 558-567
14. Futami K., Ishikawa Y., Goto M., Furuichi Y., and Sugimoto M. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Cancer Sci. 99 (2008) 843-848
15. Epstein C.J., Martin G.M., Schultz A.L., and Motulsky A.G. Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 45 (1966) 177-221
16. Goto M. Hierarchical deterioration of body systems in Werner's syndrome: implications for normal ageing. Mech. Ageing Dev. 98 (1997) 239-254
17. Gray M.D., Shen J.C., Kamath-Loeb A.S., Blank A., Sopher B.L., Martin G.M., Oshima J., and Loeb L.A. The Werner syndrome protein is a DNA helicase. Nat. Genet. 17 (1997) 100-103
18. Huang S., Li B., Gray M.D., Oshima J., Mian I.S., and Campisi J. The premature ageing syndrome protein, WRN, is a 3′→5′ exonuclease. Nat. Genet. 20 (1998) 114-116
19. Kamath-Loeb A.S., Shen J.C., Loeb L.A., and Fry M. Werner syndrome protein. II. Characterization of the integral 3′ → 5′ DNA exonuclease. J. Biol. Chem. 273 (1998) 34145-34150
20. Machwe A., Xiao L., Groden J., Matson S.W., and Orren D.K. RecQ family members combine strand pairing and unwinding activities to catalyze strand exchange. J. Biol. Chem. 280 (2005) 23397-23407
21. Shen J.C., Gray M.D., Oshima J., and Loeb L.A. Characterization of Werner syndrome protein DNA helicase activity: directionality, substrate dependence and stimulation by replication protein A. Nucleic Acids Res. 26 (1998) 2879-2885
22. Shen J.C., Gray M.D., Oshima J., Kamath-Loeb A.S., Fry M., and Loeb L.A. Werner syndrome protein. I. DNA helicase and dna exonuclease reside on the same polypeptide. J. Biol. Chem. 273 (1998) 34139-34144
23. Suzuki N., Shimamoto A., Imamura O., Kuromitsu J., Kitao S., Goto M., and Furuichi Y. DNA helicase activity in Werner's syndrome gene product synthesized in a baculovirus system. Nucleic Acids Res. 25 (1997) 2973-2978
24. Huang S., Beresten S., Li B., Oshima J., Ellis N.A., and Campisi J. Characterization of the human and mouse WRN 3′ → 5′ exonuclease. Nucleic Acids Res. 28 (2000) 2396-2405
25. Xue Y., Ratcliff G.C., Wang H., vis-Searles P.R., Gray M.D., Erie D.A., and Redinbo M.R. A minimal exonuclease domain of WRN forms a hexamer on DNA and possesses both 3′-5′ exonuclease and 5′-protruding strand endonuclease activities. Biochemistry 41 (2002) 2901-2912
26. Compton S.A., Tolun G., Kamath-Loeb A.S., Loeb L.A., and Griffith J.D. The Werner syndrome protein binds replication fork and Holliday junction DNAs as an oligomer. J. Biol. Chem. 283 (2008) 24478-24483
27. Choudhary S., Sommers J.A., and Brosh Jr. R.M. Biochemical and kinetic characterization of the DNA helicase and exonuclease activities of Werner syndrome protein. J. Biol. Chem. 279 (2004) 34603-34613
28. Hyun M., Bohr V.A., and Ahn B. Biochemical characterization of the WRN-1 RecQ helicase of Caenorhabditis elegans. Biochemistry 47 (2008) 7583-7593
29. Lee S.J., Yook J.S., Han S.M., and Koo H.S. A Werner syndrome protein homolog affects C. elegans development, growth rate, life span and sensitivity to DNA damage by acting at a DNA damage checkpoint. Development 131 (2004) 2565-2575
30. Boubriak I., Mason P.A., Clancy D.J., Dockray J., Saunders R.D., and Cox L.S. DmWRNexo is a 3′-5′ exonuclease: phenotypic and biochemical characterization of mutants of the Drosophila orthologue of human WRN exonuclease. Biogerontology 10 (2009) 267-277
31. Cox L.S., Clancy D.J., Boubriak I., and Saunders R.D. Modeling Werner Syndrome in Drosophila melanogaster: hyper-recombination in flies lacking WRN-like exonuclease. Ann. N. Y. Acad. Sci. 1119 (2007) 274-288
32. Saunders R.D., Boubriak I., Clancy D.J., and Cox L.S. Identification and characterization of a Drosophila ortholog of WRN exonuclease that is required to maintain genome integrity. Aging Cell 7 (2008) 418-425
33. Yan H., Chen C.Y., Kobayashi R., and Newport J. Replication focus-forming activity 1 and the Werner syndrome gene product. Nat. Genet. 19 (1998) 375-378
34. Mohaghegh P., Karow J.K., Brosh Jr. J.R., Bohr V.A., and Hickson I.D. The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases. Nucleic Acids Res. 29 (2001) 2843-2849
35. Orren D.K., Theodore S., and Machwe A. The Werner syndrome helicase/exonuclease (WRN) disrupts and degrades D-loops in vitro. Biochemistry 41 (2002) 13483-13488
36. Harrigan J.A., Piotrowski J., Di N.L., Levine R.L., Levine R.L., and Bohr V.A. Metal-catalyzed oxidation of the Werner syndrome protein causes loss of catalytic activities and impaired protein-protein interactions. J. Biol. Chem. 282 (2007) 36403-36411
37. Karmakar P., Piotrowski J., Brosh Jr. R.M., Sommers J.A., Miller S.P., Cheng W.H., Snowden C.M., Ramsden D.A., and Bohr V.A. Werner protein is a target of DNA-dependent protein kinase in vivo and in vitro, and its catalytic activities are regulated by phosphorylation. J. Biol. Chem. 277 (2002) 18291-18302
38. Yannone S.M., Roy S., Chan D.W., Murphy M.B., Huang S., Campisi J., and Chen D.J. Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J. Biol. Chem. 276 (2001) 38242-38248
39. Cheng W.H., von K.C., Opresko P.L., Fields K.M., Ren J., Kufe D., and Bohr V.A. Werner syndrome protein phosphorylation by abl tyrosine kinase regulates its activity and distribution. Mol. Cell Biol. 23 (2003) 6385-6395
40. Muftuoglu M., Kusumoto R., Speina E., Beck G., Cheng W.H., and Bohr V.A. Acetylation regulates WRN catalytic activities and affects base excision DNA repair. PLoS One 3 (2008) e1918
41. Woods Y.L., Xirodimas D.P., Prescott A.R., Sparks A., Lane D.P., and Saville M.K. p14 Arf promotes small ubiquitin-like modifier conjugation of Werners helicase. J. Biol. Chem. 279 (2004) 50157-50166
42. Agrelo R., Cheng W.H., Setien F., Ropero S., Espada J., Fraga M.F., Herranz M., Paz M.F., Sanchez-Cespedes M., Artiga M.J., Guerrero D., Castells A., von K.C., Bohr V.A., and Esteller M. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8822-8827
43. Opresko P.L., Calvo J.P., and von K.C. Role for the Werner syndrome protein in the promotion of tumor cell growth. Mech. Ageing Dev. 128 (2007) 423-436
44. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum. Mol. Genet. 16 (2007) R50-R59
45. Futami K., Takagi M., Shimamoto A., Sugimoto M., and Furuichi Y. Increased chemotherapeutic activity of camptothecin in cancer cells by siRNA-induced silencing of WRN helicase. Biol. Pharm. Bull. 30 (2007) 1958-1961
46. Wang Z., Xu Y., Tang J., Ma H., Qin J., Lu C., Wang X., Hu Z., Wang X., and Shen H. A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women. Breast Cancer Res. Treat. (2009)
47. Wirtenberger M., Frank B., Hemminki K., Klaes R., Schmutzler R.K., Wappenschmidt B., Meindl A., Kiechle M., Arnold N., Weber B.H., Niederacher D., Bartram C.R., and Burwinkel B. Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer. Carcinogenesis 27 (2006) 1655-1660
48. Bohr V.A., Metter E.J., Harrigan J.A., von K.C., Liu J.L., Gray M.D., Majumdar A., Wilson III D.M., and Seidman M.M. Werner syndrome protein 1367 variants and disposition towards coronary artery disease in Caucasian patients. Mech. Ageing Dev. 125 (2004) 491-496
49. Kamath-Loeb A.S., Welcsh P., Waite M., Adman E.T., and Loeb L.A. The enzymatic activities of the Werner syndrome protein are disabled by the amino acid polymorphism R834C. J. Biol. Chem. 279 (2004) 55499-55505
50. Blander G., Kipnis J., Leal J.F., Yu C.E., Schellenberg G.D., and Oren M. Physical and functional interaction between p53 and the Werner's syndrome protein. J. Biol. Chem. 274 (1999) 29463-29469
51. Cheng W.H., Kusumoto R., Opresko P.L., Sui X., Huang S., Nicolette M.L., Paull T.T., Campisi J., Seidman M., and Bohr V.A. Collaboration of Werner syndrome protein and BRCA1 in cellular responses to DNA interstrand cross-links. Nucleic Acids Res. 34 (2006) 2751-2760
52. Ding S.L., Yu J.C., Chen S.T., Hsu G.C., and Shen C.Y. Genetic variation in the premature aging gene WRN: a case-control study on breast cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 263-269
53. Pinto G.R., Yoshioka F.K., Clara C.A., Santos M.J., Almeida J.R., Burbano R.R., Rey J.A., and Casartelli C. WRN Cys1367Arg SNP is not associated with risk and prognosis of gliomas in Southeast Brazil. J. Neurooncol. 90 (2008) 253-258
54. Hirai M., Suzuki S., Hinokio Y., Yamada T., Yoshizumi S., Suzuki C., Satoh J., and Oka Y. WRN gene 1367 Arg allele protects against development of type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 69 (2005) 287-292
55. Nakayama R., Sato Y., Masutani M., Ogino H., Nakatani F., Chuman H., Beppu Y., Morioka H., Yabe H., Hirose H., Sugimura H., Sakamoto H., Ohta T., Toyama Y., Yoshida T., and Kawai A. Association of a missense single nucleotide polymorphism, Cys1367Arg of the WRN gene, with the risk of bone and soft tissue sarcomas in Japan. Cancer Sci. 99 (2008) 333-339
56. Shen M., Zheng T., Lan Q., Zhang Y., Zahm S.H., Wang S.S., Holford T.R., Leaderer B., Yeager M., Welch R., Kang D., Boyle P., Zhang B., Zou K., Zhu Y., Chanock S., and Rothman N. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum. Genet. 119 (2006) 659-668
57. Castro E., Edland S.D., Lee L., Ogburn C.E., Deeb S.S., Brown G., Panduro A., Riestra R., Tilvis R., Louhija J., Penttinen R., Erkkola R., Wang L., Martin G.M., and Oshima J. Polymorphisms at the Werner locus: II. 1074Leu/Phe, 1367Cys/Arg, longevity, and atherosclerosis. Am. J. Med. Genet. 95 (2000) 374-380
58. Ye L., Miki T., Nakura J., Oshima J., Kamino K., Rakugi H., Ikegami H., Higaki J., Edland S.D., Martin G.M., and Ogihara T. Association of a polymorphic variant of the Werner helicase gene with myocardial infarction in a Japanese population. Am. J. Med. Genet. 68 (1997) 494-498
59. Castro E., Oviedo-Rodriguez V., and ngel-Chavez L.I. WRN polymorphisms affect expression levels of plasminogen activator inhibitor type 1 in cultured fibroblasts. BMC Cardiovasc. Disord. 8 (2008) 5
60. Murano S., Nakazawa A., Saito I., Masuda M., Morisaki N., Akikusa B., Tsuboyama T., and Saito Y. Increased blood plasminogen activator inhibitor-1 and intercellular adhesion molecule-1 as possible risk factors of atherosclerosis in Werner syndrome. Gerontology 43 Suppl 1 (1997) 43-52
61. Chen L., Lee L., Kudlow B.A., dos Santos H.G., Sletvold O., Shafeghati Y., Botha E.G., Garg A., Hanson N.B., Martin G.M., Mian I.S., Kennedy B.K., and Oshima J. LMNA mutations in atypical Werner's syndrome. Lancet 362 (2003) 440-445
62. Doh Y.J., Kim H.K., Jung E.D., Choi S.H., Kim J.G., Kim B.W., and Lee I.K. Novel LMNA gene mutation in a patient with Atypical Werner's Syndrome. Korean J. Intern. Med. 24 (2009) 68-72
63. Jacob K.N., Baptista F., dos Santos H.G., Oshima J., Agarwal A.K., and Garg A. Phenotypic heterogeneity in body fat distribution in patients with atypical Werner's syndrome due to heterozygous Arg133Leu lamin A/C mutation. J. Clin. Endocrinol. Metab. 90 (2005) 6699-6706
64. Renard D., Fourcade G., Milhaud D., Bessis D., Esteves-Vieira V., Boyer A., Roll P., Bourgeois P., Levy N., and De Sandre-Giovannoli A. Novel LMNA mutation in atypical Werner syndrome presenting with ischemic disease. Stroke 40 (2009) e11-e14
65. Dhillon K.K., Sidorova J., Saintigny Y., Poot M., Gollahon K., Rabinovitch P.S., and Monnat Jr. R.J. Functional role of the Werner syndrome RecQ helicase in human fibroblasts. Aging Cell 6 (2007) 53-61
66. Hanaoka F., Yamada M., Takeuchi F., Goto M., Miyamoto T., and Hori T. Autoradiographic studies of DNA replication in Werner's syndrome cells. Adv. Exp. Med. Biol. 190 (1985) 439-457
67. Poot M., Hoehn H., Runger T.M., and Martin G.M. Impaired S-phase transit of Werner syndrome cells expressed in lymphoblastoid cell lines. Exp. Cell Res. 202 (1992) 267-273
68. Rodriguez-Lopez A.M., Jackson D.A., Iborra F., and Cox L.S. Asymmetry of DNA replication fork progression in Werner's syndrome. Aging Cell 1 (2002) 30-39
69. Takeuchi F., Hanaoka F., Goto M., Yamada M., and Miyamoto T. Prolongation of S phase and whole cell cycle in Werner's syndrome fibroblasts. Exp. Gerontol. 17 (1982) 473-480
70. Fujiwara Y., Higashikawa T., and Tatsumi M. A retarded rate of DNA replication and normal level of DNA repair in Werner's syndrome fibroblasts in culture. J. Cell Physiol. 92 (1977) 365-374
71. Fujiwara Y., Kano Y., Ichihashi M., Nakao Y., and Matsumura T. Abnormal fibroblast aging and DNA replication in the Werner syndrome. Adv. Exp. Med. Biol. 190 (1985) 459-477
72. Hanaoka F., Takeuchi F., Matsumura T., Goto M., Miyamoto T., and Yamada M. Decrease in the average size of replicons in a Werner syndrome cell line by Simian virus 40 infection. Exp. Cell Res. 144 (1983) 463-467
73. Takeuchi F., Hanaoka F., Goto M., Akaoka I., Hori T., Yamada M., and Miyamoto T. Altered frequency of initiation sites of DNA replication in Werner's syndrome cells. Hum. Genet. 60 (1982) 365-368
74. Sidorova J.M., Li N., Folch A., and Monnat Jr. R.J. The RecQ helicase WRN is required for normal replication fork progression after DNA damage or replication fork arrest. Cell Cycle 7 (2008) 796-807
75. Pichierri P., Franchitto A., Mosesso P., and Palitti F. Werner's syndrome protein is required for correct recovery after replication arrest and DNA damage induced in S-phase of cell cycle. Mol. Biol. Cell 12 (2001) 2412-2421
76. Rodriguez-Lopez A.M., Whitby M.C., Borer C.M., Bachler M.A., and Cox L.S. Correction of proliferation and drug sensitivity defects in the progeroid Werner's Syndrome by Holliday junction resolution. Rejuvenation Res. 10 (2007) 27-40
77. Salk D., Bryant E., Hoehn H., Johnston P., and Martin G.M. Growth characteristics of Werner syndrome cells in vitro. Adv. Exp. Med. Biol. 190 (1985) 305-311
78. Champoux J.J. DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 70 (2001) 369-413
79. Leppard J.B., and Champoux J.J. Human DNA topoisomerase I: relaxation, roles, and damage control. Chromosoma 114 (2005) 75-85
80. Wang J.C. DNA topoisomerases. Annu. Rev. Biochem. 65 (1996) 635-692
81. Christmann M., Tomicic M.T., Gestrich C., Roos W.P., Bohr V.A., and Kaina B. WRN protects against topo I but not topo II inhibitors by preventing DNA break formation. DNA Repair (Amst) 7 (2008) 1999-2009
82. Franchitto A., Pirzio L.M., Prosperi E., Sapora O., Bignami M., and Pichierri P. Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81-dependent pathway. J. Cell Biol. 183 (2008) 241-252
83. Bridgewater L.C., Manning F.C., and Patierno S.R. Arrest of replication by mammalian DNA polymerases alpha and beta caused by chromium-DNA lesions. Mol. Carcinog. 23 (1998) 201-206
84. O'Brien T., Mandel H.G., Pritchard D.E., and Patierno S.R. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions. Biochemistry 41 (2002) 12529-12537
85. Ha L., Ceryak S., and Patierno S.R. Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of gamma-H2AX. Carcinogenesis 25 (2004) 2265-2274
86. Reynolds M.F., Peterson-Roth E.C., Bespalov I.A., Johnston T., Gurel V.M., Menard H.L., and Zhitkovich A. Rapid DNA double-strand breaks resulting from processing of Cr-DNA cross-links by both MutS dimers. Cancer Res. 69 (2009) 1071-1079
87. Liu F.J., Barchowsky A., and Opresko P.L. The Werner syndrome protein functions in repair of Cr(VI)-induced replication-associated DNA damage. Toxicol. Sci. 110 (2009) 307-318
88. Sharma S., Otterlei M., Sommers J.A., Driscoll H.C., Dianov G.L., Kao H.I., Bambara R.A., and Brosh Jr. R.M. WRN helicase and FEN-1 form a complex upon replication arrest and together process branchmigrating DNA structures associated with the replication fork. Mol. Biol. Cell 15 (2004) 734-750
89. Bartek J., Lukas C., and Lukas J. Checking on DNA damage in S phase. Nat. Rev. Mol. Cell Biol. 5 (2004) 792-804
90. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15 (2001) 2177-2196
91. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3 (2003) 155-168
92. Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 31 (2006) 402-410
93. Shechter D., Costanzo V., and Gautier J. Regulation of DNA replication by ATR: signaling in response to DNA intermediates. DNA Repair (Amst) 3 (2004) 901-908
94. Cheng W.H., Muftic D., Muftuoglu M., Dawut L., Morris C., Helleday T., Shiloh Y., and Bohr V.A. WRN is required for ATM activation and the S-phase checkpoint in response to interstrand cross-link-induced DNA double-strand breaks. Mol. Biol. Cell 19 (2008) 3923-3933
95. Pichierri P., Rosselli F., and Franchitto A. Werner's syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle. Oncogene 22 (2003) 1491-1500
96. Otterlei M., Bruheim P., Ahn B., Bussen W., Karmakar P., Baynton K., and Bohr V.A. Werner syndrome protein participates in a complex with RAD51, RAD54, RAD54B and ATR in response to ICL-induced replication arrest. J. Cell Sci. 119 (2006) 5137-5146
97. Robinson K., Asawachaicharn N., Galloway D.A., and Grandori C. c-Myc accelerates S-Phase and requires WRN to avoid replication stress. PLoS One 4 (2009) e5951
98. Dang C.V., O'Donnell K.A., Zeller K.I., Nguyen T., Osthus R.C., and Li F. The c-Myc target gene network. Semin. Cancer Biol. 16 (2006) 253-264
99. Dominguez-Sola D., Ying C.Y., Grandori C., Ruggiero L., Chen B., Li M., Galloway D.A., Gu W., Gautier J., and la-Favera R. Non-transcriptional control of DNA replication by c-Myc. Nature 448 (2007) 445-451
100. Pirzio L.M., Pichierri P., Bignami M., and Franchitto A. Werner syndrome helicase activity is essential in maintaining fragile site stability. J. Cell Biol. 180 (2008) 305-314
101. Casper A.M., Nghiem P., Arlt M.F., and Glover T.W. ATR regulates fragile site stability. Cell 111 (2002) 779-789
102. Glover T.W., Berger C., Coyle J., and Echo B. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 67 (1984) 136-142
103. Glover T.W., Arlt M.F., Casper A.M., and Durkin S.G. Mechanisms of common fragile site instability. Hum. Mol. Genet. 14 Spec No. 2 (2005) R197-R205
104. Kamath-Loeb A.S., Loeb L.A., Johansson E., Burgers P.M., and Fry M. Interactions between the Werner syndrome helicase and DNA polymerase delta specifically facilitate copying of tetraplex and hairpin structures of the d(CGG)n trinucleotide repeat sequence. J. Biol. Chem. 276 (2001) 16439-16446
105. Kamath-Loeb A.S., Johansson E., Burgers P.M., and Loeb L.A. Functional interaction between the Werner Syndrome protein and DNA polymerase delta. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4603-4608
106. Szekely A.M., Chen Y.H., Zhang C., Oshima J., and Weissman S.M. Werner protein recruits DNA polymerase delta to the nucleolus. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 11365-11370
107. Lebel M., Spillare E.A., Harris C.C., and Leder P. The Werner syndrome gene product co-purifies with the DNA replication complex and interacts with PCNA and topoisomerase I. J. Biol. Chem. 274 (1999) 37795-37799
108. Rodriguez-Lopez A.M., Jackson D.A., Nehlin J.O., Iborra F., Warren A.V., and Cox L.S. Characterisation of the interaction between WRN, the helicase/exonuclease defective in progeroid Werner's syndrome, and an essential replication factor, PCNA. Mech. Ageing Dev. 124 (2003) 167-174
109. Brosh Jr. R.M., von K.C., Sommers J.A., Karmakar P., Opresko P.L., Piotrowski J., Dianova I., Dianov G.L., and Bohr V.A. Werner syndrome protein interacts with human flap endonuclease 1 and stimulates its cleavage activity. EMBO J. 20 (2001) 5791-5801
110. Brosh Jr. R.M., Driscoll H.C., Dianov G.L., and Sommers J.A. Biochemical characterization of the WRN-FEN-1 functional interaction. Biochemistry 41 (2002) 12204-12216
111. Sharma S., Sommers J.A., and Brosh Jr. R.M. In vivo function of the conserved non-catalytic domain of Werner syndrome helicase in DNA replication. Hum. Mol. Genet. 13 (2004) 2247-2261
112. Sharma S., Sommers J.A., Gary R.K., Friedrich-Heineken E., Hubscher U., and Brosh Jr. R.M. The interaction site of Flap Endonuclease-1 with WRN helicase suggests a coordination of WRN and PCNA. Nucleic Acids Res. 33 (2005) 6769-6781
113. Zheng L., Zhou M., Chai Q., Parrish J., Xue D., Patrick S.M., Turchi J.J., Yannone S.M., Chen D., and Shen B. Novel function of the flap endonuclease 1 complex in processing stalled DNA replication forks. EMBO Rep. 6 (2005) 83-89
114. Brosh Jr. R.M., Orren D.K., Nehlin J.O., Ravn P.H., Kenny M.K., Machwe A., and Bohr V.A. Functional and physical interaction between WRN helicase and human replication protein A. J. Biol. Chem. 274 (1999) 18341-18350
115. Doherty K.M., Sommers J.A., Gray M.D., Lee J.W., von K.C., Thoma N.H., Kureekattil R.P., Kenny M.K., and Brosh Jr. R.M. Physical and functional mapping of the replication protein a interaction domain of the werner and bloom syndrome helicases. J. Biol. Chem. 280 (2005) 29494-29505
116. Shen J.C., Lao Y., Kamath-Loeb A., Wold M.S., and Loeb L.A. The N-terminal domain of the large subunit of human replication protein A binds to Werner syndrome protein and stimulates helicase activity. Mech. Ageing Dev. 124 (2003) 921-930
117. Wang W., and Bambara R.A. Human Bloom protein stimulates flap endonuclease 1 activity by resolving DNA secondary structure. J. Biol. Chem. 280 (2005) 5391-5399
118. Chen C.Y., Graham J., and Yan H. Evidence for a replication function of FFA-1, the Xenopus orthologue of Werner syndrome protein. J. Cell Biol. 152 (2001) 985-996
119. Yan H., and Newport J. FFA-1, a protein that promotes the formation of replication centers within nuclei. Science 269 (1995) 1883-1885
120. Sasakawa N., Fukui T., and Waga S. Accumulation of FFA-1, the Xenopus homolog of Werner helicase, and DNA polymerase delta on chromatin in response to replication fork arrest. J. Biochem. 140 (2006) 95-103
121. Lindahl T. Instability and decay of the primary structure of DNA. Nature 362 (1993) 709-715
122. Friedberg E.C., Aguilera A., Gellert M., Hanawalt P.C., Hays J.B., Lehmann A.R., Lindahl T., Lowndes N., Sarasin A., and Wood R.D. DNA repair: from molecular mechanism to human disease. DNA Repair (Amst) 5 (2006) 986-996
123. Brosh Jr. R.M., Karmakar P., Sommers J.A., Yang Q., Wang X.W., Spillare E.A., Harris C.C., and Bohr V.A. p53 Modulates the exonuclease activity of Werner syndrome protein. J. Biol. Chem. 276 (2001) 35093-35102
124. Sommers J.A., Sharma S., Doherty K.M., Karmakar P., Yang Q., Kenny M.K., Harris C.C., and Brosh Jr. R.M. p53 modulates RPA-dependent and RPA-independent WRN helicase activity. Cancer Res. 65 (2005) 1223-1233
125. Yang Q., Zhang R., Wang X.W., Spillare E.A., Linke S.P., Subramanian D., Griffith J.D., Li J.L., Hickson I.D., Shen J.C., Loeb L.A., Mazur S.J., Appella E., Brosh Jr. R.M., Karmakar P., Bohr V.A., and Harris C.C. The processing of Holliday junctions by BLM and WRN helicases is regulated by p53. J. Biol. Chem. 277 (2002) 31980-31987
126. Spillare E.A., Robles A.I., Wang X.W., Shen J.C., Yu C.E., Schellenberg G.D., and Harris C.C. p53-mediated apoptosis is attenuated in Werner syndrome cells. Genes Dev. 13 (1999) 1355-1360
127. Gebhart E., Bauer R., Raub U., Schinzel M., Ruprecht K.W., and Jonas J.B. Spontaneous and induced chromosomal instability in Werner syndrome. Hum. Genet. 80 (1988) 135-139
128. Grigorova M., Balajee A.S., and Natarajan A.T. Spontaneous and X-ray-induced chromosomal aberrations in Werner syndrome cells detected by FISH using chromosome-specific painting probes. Mutagenesis 15 (2000) 303-310
129. Imamura O., Fujita K., Itoh C., Takeda S., Furuichi Y., and Matsumoto T. Werner and Bloom helicases are involved in DNA repair in a complementary fashion. Oncogene 21 (2002) 954-963
130. Ogburn C.E., Oshima J., Poot M., Chen R., Hunt K.E., Gollahon K.A., Rabinovitch P.S., and Martin G.M. An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum. Genet. 101 (1997) 121-125
131. Poot M., Gollahon K.A., and Rabinovitch P.S. Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase. Hum. Genet. 104 (1999) 10-14
132. Harrigan J.A., Wilson III D.M., Prasad R., Opresko P.L., Beck G., May A., Wilson S.H., and Bohr V.A. The Werner syndrome protein operates in base excision repair and cooperates with DNA polymerase beta. Nucleic Acids Res. 34 (2006) 745-754
133. von Kobbe C., May A., Grandori C., and Bohr V.A. Werner syndrome cells escape hydrogen peroxide-induced cell proliferation arrest. FASEB J. 18 (2004) 1970-1972
134. Bohr V.A. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic. Biol. Med. 32 (2002) 804-812
135. Fortini P., Pascucci B., Parlanti E., D'Errico M., Simonelli V., and Dogliotti E. 8-Oxoguanine DNA damage: at the crossroad of alternative repair pathways. Mutat. Res. 531 (2003) 127-139
136. Szekely A.M., Bleichert F., Numann A., Van K.S., Manasanch E., Ben N.A., Canaan A., and Weissman S.M. Werner protein protects nonproliferating cells from oxidative DNA damage. Mol. Cell Biol. 25 (2005) 10492-10506
137. Blank A., Bobola M.S., Gold B., Varadarajan S., Kolstoe D., Meade E.H., Rabinovitch P.S., Loeb L.A., and Silber J.R. The Werner syndrome protein confers resistance to the DNA lesions N3-methyladenine and O6-methylguanine: implications for WRN function. DNA Repair (Amst) 3 (2004) 629-638
138. Dianov G.L., Prasad R., Wilson S.H., and Bohr V.A. Role of DNA polymerase beta in the excision step of long patch mammalian base excision repair. J. Biol. Chem. 274 (1999) 13741-13743
139. Sobol R.W., Horton J.K., Kuhn R., Gu H., Singhal R.K., Prasad R., Rajewsky K., and Wilson S.H. Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature 379 (1996) 183-186
140. Harrigan J.A., Opresko P.L., von K.C., Kedar P.S., Prasad R., Wilson S.H., and Bohr V.A. The Werner syndrome protein stimulates DNA polymerase beta strand displacement synthesis via its helicase activity. J. Biol. Chem. 278 (2003) 22686-22695
141. Harrigan J.A., Fan J., Momand J., Perrino F.W., Bohr V.A., and Wilson III D.M. WRN exonuclease activity is blocked by DNA termini harboring 3′ obstructive groups. Mech. Ageing Dev. 128 (2007) 259-266
142. Ahn B., Harrigan J.A., Indig F.E., Wilson III D.M., and Bohr V.A. Regulation of WRN helicase activity in human base excision repair. J. Biol. Chem. 279 (2004) 53465-53474
143. Das A., Boldogh I., Lee J.W., Harrigan J.A., Hegde M.L., Piotrowski J., de Souza-Pinto N., Ramos W., Greenberg M.M., Hazra T.K., Mitra S., and Bohr V.A. The human Werner syndrome protein stimulates repair of oxidative DNA base damage by the DNA glycosylase Neil1. J. Biol. Chem. 282 (2007) 26591-26602
144. Imoto S., Patro J.N., Jiang Y.L., Oka N., and Greenberg M.M. Synthesis, DNA polymerase incorporation, and enzymatic phosphate hydrolysis of formamidopyrimidine nucleoside triphosphates. J. Am. Chem. Soc. 128 (2006) 14606-14611
145. von Kobbe C., Harrigan J.A., May A., Opresko P.L., Dawut L., Cheng W.H., and Bohr V.A. Central role for the Werner syndrome protein/poly(ADP-ribose) polymerase 1 complex in the poly(ADP-ribosyl)ation pathway after DNA damage. Mol. Cell Biol. 23 (2003) 8601-8613
146. Blander G., Zalle N., Daniely Y., Taplick J., Gray M.D., and Oren M. DNA damage-induced translocation of the Werner helicase is regulated by acetylation. J. Biol. Chem. 277 (2002) 50934-50940
147. Li K., Casta A., Wang R., Lozada E., Fan W., Kane S., Ge Q., Gu W., Orren D., and Luo J. Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation. J. Biol. Chem. 283 (2008) 7590-7598
148. Kahyo T., Mostoslavsky R., Goto M., and Setou M. Sirtuin-mediated deacetylation pathway stabilizes Werner syndrome protein. FEBS Lett. 582 (2008) 2479-2483
149. Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H., Damian M., Cheung P., Kusumoto R., Kawahara T.L., Barrett J.C., Chang H.Y., Bohr V.A., Ried T., Gozani O., and Chua K.F. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452 (2008) 492-496
150. Lan L., Nakajima S., Komatsu K., Nussenzweig A., Shimamoto A., Oshima J., and Yasui A. Accumulation of Werner protein at DNA double-strand breaks in human cells. J. Cell Sci. 118 (2005) 4153-4162
151. Galvan N., Lim S., Zmugg S., Smith M.T., and Zhang L. Depletion of WRN enhances DNA damage in HeLa cells exposed to the benzene metabolite, hydroquinone. Mutat. Res. 649 (2008) 54-61
152. Ren X., Lim S., Smith M.T., and Zhang L. Werner syndrome protein, WRN, protects cells from DNA damage induced by the benzene metabolite hydroquinone. Toxicol. Sci. 107 (2009) 367-375
153. Cooper M.P., Machwe A., Orren D.K., Brosh R.M., Ramsden D., and Bohr V.A. Ku complex interacts with and stimulates the Werner protein. Genes Dev. 14 (2000) 907-912
154. Karmakar P., Snowden C.M., Ramsden D.A., and Bohr V.A. Ku heterodimer binds to both ends of the Werner protein and functional interaction occurs at the Werner N-terminus. Nucleic Acids Res. 30 (2002) 3583-3591
155. Li B., and Comai L. Requirements for the nucleolytic processing of DNA ends by the Werner syndrome protein-Ku70/80 complex. J. Biol. Chem. 276 (2001) 9896-9902
156. Orren D.K., Machwe A., Karmakar P., Piotrowski J., Cooper M.P., and Bohr V.A. A functional interaction of Ku with Werner exonuclease facilitates digestion of damaged DNA. Nucleic Acids Res. 29 (2001) 1926-1934
157. Bukowy Z., Harrigan J.A., Ramsden D.A., Tudek B., Bohr V.A., and Stevnsner T. WRN Exonuclease activity is blocked by specific oxidatively induced base lesions positioned in either DNA strand. Nucleic Acids Res. 36 (2008) 4975-4987
158. Li B., and Comai L. Displacement of DNA-PKcs from DNA ends by the Werner syndrome protein. Nucleic Acids Res. 30 (2002) 3653-3661
159. Kusumoto R., Dawut L., Marchetti C., Wan L.J., Vindigni A., Ramsden D., and Bohr V.A. Werner protein cooperates with the XRCC4-DNA ligase IV complex in end-processing. Biochemistry 47 (2008) 7548-7556
160. Saintigny Y., Makienko K., Swanson C., Emond M.J., and Monnat Jr. R.J. Homologous recombination resolution defect in werner syndrome. Mol. Cell Biol. 22 (2002) 6971-6978
161. Sallmyr A., Tomkinson A.E., and Rassool F.V. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. Blood 112 (2008) 1413-1423
162. Sakamoto S., Nishikawa K., Heo S.J., Goto M., Furuichi Y., and Shimamoto A. Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51. Genes Cells 6 (2001) 421-430
163. Baynton K., Otterlei M., Bjoras M., von K.C., Bohr V.A., and Seeberg E. WRN interacts physically and functionally with the recombination mediator protein RAD52. J. Biol. Chem. 278 (2003) 36476-36486
164. Cheng W.H., von K.C., Opresko P.L., Arthur L.M., Komatsu K., Seidman M.M., Carney J.P., and Bohr V.A. Linkage between Werner syndrome protein and the Mre11 complex via Nbs1. J. Biol. Chem. 279 (2004) 21169-21176
165. Poot M., Yom J.S., Whang S.H., Kato J.T., Gollahon K.A., and Rabinovitch P.S. Werner syndrome cells are sensitive to DNA cross-linking drugs. FASEB J. 15 (2001) 1224-1226
166. Laine J.P., Opresko P.L., Indig F.E., Harrigan J.A., von K.C., and Bohr V.A. Werner protein stimulates topoisomerase I DNA relaxation activity. Cancer Res. 63 (2003) 7136-7146
167. Aggarwal M., and Brosh Jr. R.M. Premature aging syndrome gene WRN genetically interacts with a topoisomerase. Cell Cycle 8 (2009) 2143
168. Thompson L.H., and Schild D. Recombinational DNA repair and human disease. Mutat. Res. 509 (2002) 49-78
169. von Kobbe C., Karmakar P., Dawut L., Opresko P., Zeng X., Brosh Jr. R.M., Hickson I.D., and Bohr V.A. Colocalization, physical, and functional interaction between Werner and Bloom syndrome proteins. J. Biol. Chem. 277 (2002) 22035-22044
170. Gray M.D., Wang L., Youssoufian H., Martin G.M., and Oshima J. Werner helicase is localized to transcriptionally active nucleoli of cycling cells. Exp. Cell Res. 242 (1998) 487-494
171. Shiratori M., Suzuki T., Itoh C., Goto M., Furuichi Y., and Matsumoto T. WRN helicase accelerates the transcription of ribosomal RNA as a component of an RNA polymerase I-associated complex. Oncogene 21 (2002) 2447-2454
172. Machwe A., Orren D.K., and Bohr V.A. Accelerated methylation of ribosomal RNA genes during the cellular senescence of Werner syndrome fibroblasts. Faseb J. 14 (2000) 1715-1724
173. Balajee A.S., Machwe A., May A., Gray M.D., Oshima J., Martin G.M., Nehlin J.O., Brosh R., Orren D.K., and Bohr V.A. The Werner syndrome protein is involved in RNA polymerase II transcription. Mol. Biol. Cell 10 (1999) 2655-2668
174. Lutomska A., Lebedev A., Scharffetter-Kochanek K., and Iben S. The transcriptional response to distinct growth factors is impaired in Werner syndrome cells. Exp. Gerontol. 43 (2008) 820-826
175. Kyng K.J., May A., Kolvraa S., and Bohr V.A. Gene expression profiling in Werner syndrome closely resembles that of normal aging. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 12259-12264
176. Olovniko A.M. Principle of marginotomy in template synthesis of polynucleotides. Doklady Akademii Nauk Sssr 201 (1971) 1496
177. Levy M.Z., Allsopp R.C., Futcher A.B., Greider C.W., and Harley C.B. Telomere end-replication problem and cell aging. J. Mol. Biol. 225 (1992) 951-960
178. Blackburn E.H., and Szostak J.W. The molecular-structure of centromeres and telomeres. Annu. Rev. Biochem. 53 (1984) 163-194
179. Greenberg R.A. Telomeres, crisis and cancer. Curr. Mol. Med. 5 (2005) 213-218
180. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19 (2005) 2100-2110
181. di Fagagna F.D., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., von Zglinicki T., Saretzki G., Carter N.P., and Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003) 194-198
182. di Fagagna F.D., Teo S.H., and Jackson S.P. Functional links between telomeres and proteins of the DNA-damage response. Genes Dev. 18 (2004) 1781-1799
183. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during aging of human fibroblasts. Nature 345 (1990) 458-460
184. Crabbe L., and Karlseder J. In the end, it's all structure. Curr. Mol. Med. 5 (2005) 135-143
185. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., and de Lange T. Mammalian telomeres end in a large duplex loop. Cell 97 (1999) 503-514
186. Gellert M., Lipsett M.N., and Davies D.R. Helix formation by guanylic acid. Proc. Natl. Acad. Sci. U.S.A. 48 (1962) 2013-2018
187. Parkinson G.N., Lee M.P., and Neidle S. Crystal structure of parallel quadruplexes from human telomeric DNA. Nature 417 (2002) 876-880
188. Paeschke K., Simonsson T., Postberg J., Rhodes D., and Lipps H.J. Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo. Nat. Struct. Mol. Biol. 12 (2005) 847-854
189. Randall A., and Griffith J.D. Structure of long telomeric RNA transcripts: the G-rich RNA forms a compact repeating structure containing G-quartets. J. Biol. Chem. 284 (2009) 13980-13986
190. Wai L.K. Telomeres, telomerase, and tumorigenesis-a review. MedGenMed. 6 (2004) 19
191. Greider C.W., and Blackburn E.H. Telomeres, telomerase and cancer. Scientific American 274 (1996) 92-97
192. de Lange T. Protection of mammalian telomeres. Oncogene 21 (2002) 532-540
193. Opresko P.L., von Kobbe C., Laine J.P., Harrigan J., Hickson I.D., and Bohr V.A. Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J. Biol. Chem. 277 (2002) 41110-41119
194. Opresko P.L., Otterlei M., Graakjaer J., Bruheim P., Dawut L., Kolvraa S., May A., Seidman M.M., and Bohr V.A. The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol. Cell 14 (2004) 763-774
195. Opresko P.L., Mason P.A., Podell E.R., Lei M., Hickson I.D., Cech T.R., and Bohr V.A. POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates. J. Biol. Chem. 280 (2005) 32069-32080
196. Li J.L., Harrison R.J., Reszka A.P., Brosh Jr. R.M., Bohr V.A., Neidle S., and Hickson I.D. Inhibition of the Bloom's and Werner's syndrome helicases by G-quadruplex interacting ligands. Biochemistry 40 (2001) 15194-15202
197. Chang S., Multani A.S., Cabrera N.G., Naylor M.L., Laud P., Lombard D., Pathak S., Guarente L., and DePinho R.A. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat. Genet. 36 (2004) 877-882
198. Kruk P.A., Rampino N.J., and Bohr V.A. Dna-damage and repair in telomeres-relation to aging. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 258-262
199. Crabbe L., Jauch A., Naeger C.M., Holtgreve-Grez H., and Karlseder J. Telomere dysfunction as a cause of genomic instability in Werner syndrome. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 2205-2210
200. Zhou B., Ikejima T., Watanabe T., Iwakoshi K., Idei Y., Tanuma S., and Uchiumi F. The effect of 2-deoxy-D-glucose on Werner syndrome RecQ helicase gene. FEBS Lett. 583 (2009) 1331-1336
201. Constantinou A., Tarsounas M., Karow J.K., Brosh R.M., Bohr V.A., Hickson I.D., and West S.C. Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest. EMBO Rep. 1 (2000) 80-84
202. Opresko P.L., Cheng W.H., von Kobbe C., Harrigan J.A., and Bohr V.A. Werner syndrome and the function of the Werner protein; what they can teach us about the molecular aging process. Carcinogenesis 24 (2003) 791-802
203. Crabbe L., Verdun R.E., Haggblom C.I., and Karlseder J. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 306 (2004) 1951-1953
204. Sowd G., Lei M., and Opresko P.L. Mechanism and substrate specificity of telomeric protein POT1 stimulation of the Werner syndrome helicase. Nucleic Acids Res. 36 (2008) 4242-4256
205. Zaug A.J., Podell E.R., and Cech T.R. Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 10864-10869
206. Cohen H., and Sinclair D.A. Recombination-mediated lengthening of terminal telomeric repeats requires the Sgs1 DNA helicase. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3174-3179
207. Mandell J.G., Goodrich K.J., Bahler J., and Cech T.R. Expression of a RecQ helicase homolog affects progression through crisis in fission yeast lacking telomerase. J. Biol. Chem. 280 (2005) 5249-5257
208. Li B., Jog S.P., Reddy S., and Comai L. WRN controls formation of extrachromosomal telomeric circles and is required for TRF2DeltaB-mediated telomere shortening. Mol. Cell Biol. 28 (2008) 1892-1904
209. Wu L., Multani A.S., He H., Cosme-Blanco W., Deng Y., Deng J.M., Bachilo O., Pathak S., Tahara H., Bailey S.M., Deng Y.B., Behringer R.R., and Chang S. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126 (2006) 49-62
210. Celli G.B., Denchi E.L., and de Lange T. Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat. Cell Biol. 8 (2006) U162-U885
211. Kawanishi S., Oikawa S., Murata M., Tsukitome H., and Saito I. Site-specific oxidation at GG and GGG sequences in double-stranded DNA by benzoyl peroxide as a tumor promoter. Biochemistry 38 (1999) 16733-16739
212. Newman J.P.A., Banerjee B., Fang W.R., Poonepalli A., Balakrishnan L., Low G.K.M., Bhattacharjee R.N., Akira S., Jayapal M., Melendez A.J., Baskar R., Lee H.W., and Hande M.P. Short dysfunctional telomeres impair the repair of arsenite-induced oxidative damage in mouse cells. J. Cell. Physiol. 214 (2008) 796-809
213. Satoh M., Ishikawa Y., Takahashi Y., Itoh T., Minami Y., and Nakamura M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 198 (2008) 347-353
214. Ghosh A., Rossi M.L., Croteau D.L., and Bohr V.A. Telomeric D-loops containing 8-oxo-2-deoxyguanosine are preferred substrates for Werner and Bloom syndrome helicases and are bound by POT1. J. Biol. Chem. 284 (2009) 31074-31084
215. Lombard D.B., Beard C., Johnson B., Marciniak R.A., Dausman J., Bronson R., Buhlmann J.E., Lipman R., Curry R., Sharpe A., Jaenisch R., and Guarente L. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol. Cell Biol. 20 (2000) 3286-3291
216. Du X., Shen J., Kugan N., Furth E.E., Lombard D.B., Cheung C., Pak S., Luo G., Pignolo R.J., DePinho R.A., Guarente L., and Johnson F.B. Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol. Cell Biol. 24 (2004) 8437-8446
217. Sharma S., Doherty K.M., and Brosh Jr. R.M. Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability. Biochem. J. 398 (2006) 319-337
218. German J. Bloom syndrome: a mendelian prototype of somatic mutational disease. Medicine (Baltimore) 72 (1993) 393-406
219. German J. Bloom's syndrome. Dermatol. Clin. 13 (1995) 7-18
220. Dietschy T., Shevelev I., and Stagljar I. The molecular role of the Rothmund-Thomson-, RAPADILINO- and Baller-Gerold-gene product, RECQL4: recent progress. Cell Mol. Life Sci. 64 (2007) 796-802
221. Kellermayer R. The versatile RECQL4. Genet. Med. 8 (2006) 213-216
222. Kitao S., Shimamoto A., Goto M., Miller R.W., Smithson W.A., Lindor N.M., and Furuichi Y. Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. Nat. Genet. 22 (1999) 82-84
223. Siitonen H.A., Kopra O., Kaariainen H., Haravuori H., Winter R.M., Saamanen A.M., Peltonen L., and Kestila M. Molecular defect of RAPADILINO syndrome expands the phenotype spectrum of RECQL diseases. Hum. Mol. Genet. 12 (2003) 2837-2844
224. Van M.L., Siitonen H.A., Jalkh N., Chouery E., De R.M., Delague V., Muenke M., Jabs E.W., Cai J., Wang L.L., Plon S.E., Fourneau C., Kestila M., Gillerot Y., Megarbane A., and Verloes A. Revisiting the craniosynostosis-radial ray hypoplasia association: Baller-Gerold syndrome caused by mutations in the RECQL4 gene. J. Med. Genet. 43 (2006) 148-152
225. Kaariainen H., Ryoppy S., and Norio R. RAPADILINO syndrome with radial and patellar aplasia/hypoplasia as main manifestations. Am. J. Med. Genet. 33 (1989) 346-351
226. Stinco G., Governatori G., Mattighello P., and Patrone P. Multiple cutaneous neoplasms in a patient with Rothmund-Thomson syndrome: case report and published work review. J. Dermatol. 35 (2008) 154-161
227. Vennos E.M., Collins M., and James W.D. Rothmund-Thomson syndrome: review of the world literature. J. Am. Acad. Dermatol. 27 (1992) 750-762
228. Brosh Jr. R.M., Li J.L., Kenny M.K., Karow J.K., Cooper M.P., Kureekattil R.P., Hickson I.D., and Bohr V.A. Replication protein A physically interacts with the Bloom's syndrome protein and stimulates its helicase activity. J. Biol. Chem. 275 (2000) 23500-23508
229. Cui S., Klima R., Ochem A., Arosio D., Falaschi A., and Vindigni A. Characterization of the DNA-unwinding activity of human RECQ1, a helicase specifically stimulated by human replication protein A. J. Biol. Chem. 278 (2003) 1424-1432
230. Cui S., Arosio D., Doherty K.M., Brosh Jr. R.M., Falaschi A., and Vindigni A. Analysis of the unwinding activity of the dimeric RECQ1 helicase in the presence of human replication protein A. Nucleic Acids Res. 32 (2004) 2158-2170
231. Garcia P.L., Liu Y., Jiricny J., West S.C., and Janscak P. Human RECQ5beta, a protein with DNA helicase and strand-annealing activities in a single polypeptide. EMBO J. 23 (2004) 2882-2891
232. Suzuki T., Kohno T., and Ishimi Y. DNA helicase activity in purified human RECQL4 protein. J. Biochem. 146 (2009) 327-335
233. Xu X., and Liu Y. Dual DNA unwinding activities of the Rothmund-Thomson syndrome protein, RECQ4. EMBO J. 28 (2009) 568-577
234. Fry M., and Loeb L.A. Human Werner syndrome DNA helicase unwinds tetrahelical structures of the fragile X syndrome repeat sequence d(CGG)n. J. Biol. Chem. 274 (1999) 12797-12802
235. Sun H., Karow J.K., Hickson I.D., and Maizels N. The Bloom's syndrome helicase unwinds G4 DNA. J. Biol. Chem. 273 (1998) 27587-27592
236. Popuri V., Bachrati C.Z., Muzzolini L., Mosedale G., Costantini S., Giacomini E., Hickson I.D., and Vindigni A. The Human RecQ helicases, BLM and RECQ1, display distinct DNA substrate specificities. J. Biol. Chem. 283 (2008) 17766-17776
237. Ozsoy A.Z., Ragonese H.M., and Matson S.W. Analysis of helicase activity and substrate specificity of Drosophila RECQ5. Nucleic Acids Res. 31 (2003) 1554-1564
238. Sharma S., Sommers J.A., Choudhary S., Faulkner J.K., Cui S., Andreoli L., Muzzolini L., Vindigni A., and Brosh Jr. R.M. Biochemical analysis of the DNA unwinding and strand annealing activities catalyzed by human RECQ1. J. Biol. Chem. 280 (2005) 28072-28084
239. Wold M.S. Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 66 (1997) 61-92
240. Schurman S.H., Hedayati M., Wang Z., Singh D.K., Speina E., Zhang Y., Becker K., Macris M., Sung P., Wilson III D.M., Croteau D.L., and Bohr V.A. Direct and indirect roles of RECQL4 in modulating base excision repair capacity. Hum. Mol. Genet. 18 (2009) 3470-3483
241. Sharma S., Sommers J.A., Wu L., Bohr V.A., Hickson I.D., and Brosh Jr. R.M. Stimulation of flap endonuclease-1 by the Bloom's syndrome protein. J. Biol. Chem. 279 (2004) 9847-9856
242. Aygun O., Svejstrup J., and Liu Y. A RECQ5-RNA polymerase II association identified by targeted proteomic analysis of human chromatin. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 8580-8584
243. Aygun O., Xu X., Liu Y., Takahashi H., Kong S.E., Conaway R.C., Conaway J.W., and Svejstrup J.Q. Direct inhibition of RNA polymerase II transcription by RECQL5. J. Biol. Chem. (2009)
244. Izumikawa K., Yanagida M., Hayano T., Tachikawa H., Komatsu W., Shimamoto A., Futami K., Furuichi Y., Shinkawa T., Yamauchi Y., Isobe T., and Takahashi N. Association of human DNA helicase RecQ5beta with RNA polymerase II and its possible role in transcription. Biochem. J. 413 (2008) 505-516